Last reviewed · How we verify
NCT03909503
A Case Series Evaluating a Collagen Wound Dressing to Treat Wounds
NA trial testing Porcine-derived collagen wound dressing in Wound. Withdrawn.
1 December 2021
Quick facts
| Lead sponsor | Medline Industries |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Start date | 1 September 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 February 2022 |
Drugs / interventions tested
- Porcine-derived collagen wound dressing
Conditions studied
- Wound — all drugs for Wound →
Sponsor
Medline Industries — full company profile →
Who can join
18 and older, any sex, with Wound. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic wounds are a source of significant morbidity and escalated healthcare costs. The wound care professional has a myriad of modern wound dressings to choose from, each of which has benefits and drawbacks. An understanding of how a given dressing performs in healing a particular wound is crucial in order to determine a clinical mapping of wound dressings to wound types; such a categorization would lead to more efficient clinical decision making and better patient outcomes. This case series will evaluate the ability of a porcine-derived collagen dressing to improve healing of chronic lower-extremity wounds.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03909503
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Wound
Currently open trials in the same condition.
- NCT07398534 — PICO Negative Pressure for Uninfected Foot Ulcers and Wound Dehiscence (BALPIC) · NA · active not recruiting
- NCT06957964 — Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds: A Randomized Clinical Trial · NA · recruiting
- NCT06801626 — Novel Strategies for Reducing Burn Scar Itch · Phase 3 · recruiting
- NCT06321978 — Mepilex Border Flex Utilization Pilot Spain · recruiting
- NCT06138964 — Comparing the Effect of siSPARC Microneedle Patch Versus siSPARC+siLR4A Microneedle Patch on Post-surgical Scars · Phase 2 · recruiting
Other Medline Industries trials
Trials by the same sponsor.
- NCT05755282 — Touch and Feel Evaluation of Two Foam Hand Sanitizers · Phase 4 · completed
- NCT05740332 — Wet Time for a Foam Hand Sanitizer · Phase 4 · completed
- NCT05756348 — Durability of Two Skin Barrier Protectants (SBP) · NA · completed
- NCT05742347 — Skin Protectant Textile Efficacy Study for Managing Skin Fold Conditions · NA · terminated
- NCT05250102 — Neonatal Pulse Oximetry Sensor Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03909503 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medline Industries
- Last refreshed: 20 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03909503.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing